Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

By G. Konecny, G. Pauletti, M. Pegram, M. Untch, S. Dandekar, Z. Aguilar, C. Wilson, H. Rong, I. Bauerfeind, Margret Felber and 5 more. Journal of the National Cancer Institute, 2003

643 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/e600d8cc850e014aa5497bc3b9d82b64195e6814

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Konecny
2. M. Pegram
3. R. Finn
4. N. Venkatesan
5. Guorong Yang
6. D. Slamon
7. M. Rahmeh
8. M. Untch

Citations in the corpus

• Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. (2006, methodology): “Cell lysates were prepared as described previously (26), and”